Clinical Edge Journal Scan

Is childhood maltreatment a risk factor for adult atopic dermatitis?


 

Key clinical point: Childhood maltreatment (CM) is associated with poor physical and mental health outcomes in adults; however, it was not found to be a risk factor for the development of adult atopic dermatitis (AD).

Major finding: Similar proportion of adults with and without AD (20.6% and 21.6%, respectively; P = .80) reported experiencing ≥1 type of moderate-to-severe CM, such as emotional, physical, and sexual abuse and emotional and physical neglect. Neither type of CM was associated with the development of AD in adults.

Study details: Findings are from an analysis of a cross-sectional population-based study including 2973 adults, of which 131 were diagnosed with AD.

Disclosures: This study was funded by the Federal Ministry of Education and Research and other sources. Some authors declared receiving honoraria, research funding, consulting fees, or support for attending meetings or travel from several sources.

Source: Piontek K et al. J Childhood maltreatment is not associated with atopic dermatitis in adults: Results from a cross-sectional population-based cohort study. Eur Acad Dermatol Venereol. 2022 (Aug 3). Doi: 10.1111/jdv.18480

Recommended Reading

Intralesional Human Papillomavirus Vaccine Therapy for Recalcitrant Plantar Wart Triggers Gout Flare
MDedge Dermatology
Abrocitinib more promising than dupilumab in moderate-to-severe atopic dermatitis
MDedge Dermatology
Moderate-to-severe atopic dermatitis: Long-term safety and effectiveness of tralokinumab
MDedge Dermatology
Patients with controlled atopic dermatitis can opt for dupilumab dose reduction
MDedge Dermatology
Progressive and sustained improvement in atopic dermatitis with tralokinumab plus TCS as needed
MDedge Dermatology
Dupilumab effective against pruritus in atopic dermatitis in real-life settings
MDedge Dermatology
Dupilumab effective and safe in special populations
MDedge Dermatology
Pseudoceramide+steroid cream rapidly improved skin barrier function in atopic dermatitis
MDedge Dermatology
Meta-analysis demonstrates efficacy and safety of IL-13 inhibitors in atopic dermatitis
MDedge Dermatology
Atopic dermatitis and immune abnormalities in children born to mothers with nickel exposure
MDedge Dermatology